We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Valproate and the Pregnancy Prevention Programme: exceptional circumstances.
- Authors
Watkins, Lance V; Cock, Hannah R; Angus-Leppan, Heather; Shankar, Rohit
- Abstract
An editorial is presented which offers information on the Medicines and Healthcare products Regulatory Agency (MHRA) regulations on valproate prescribing. Topics discussed include risk associated with valproate such as major congenital malformations (MCM;) information of valproate as an effective medication to manage uncontrolled seizure activity in emergency situations; and concerns related to implementing the MHRA regulations such as depriving the right to choice of contraception.
- Subjects
EUROPE; HYPOSPADIAS; VALPROIC acid; BIRTH control; RISK assessment -- Law &; legislation; ANTICONVULSANTS; PREGNANCY complications; RISK assessment; TERATOGENIC agents; DRUG control; STATUS epilepticus; DRUG-induced abnormalities; PHARMACODYNAMICS
- Publication
British Journal of General Practice, 2019, Vol 69, Issue 681, p166
- ISSN
0960-1643
- Publication type
editorial
- DOI
10.3399/bjgp19X701897